(Incorporated in Hong Kong with limited liability) （於香港註冊成立的有限公司） (Stock Code: 3320) （股份代號：3320） Dear Shareholders, 20 January 2026 Letter to those shareholders who have elected to receive the printed form of corporate communications We are pleased to enclose the Circular dated 20 January 2026 and Proxy form for use at the 2026 first extraordinary general meeting on 6 February 2026 of China Resources Pharmaceutical Group Limited (the "Company"). Please note that the 2026 first extraordinary general meeting ...